全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Kidney Transplant in a 26-Year-Old Nigerian Patient with Sickle Cell Nephropathy

DOI: 10.1155/2012/406406

Full-Text   Cite this paper   Add to My Lib

Abstract:

Sickle cell nephropathy (SCN) is a common complication of sickle cell disease (SCD). It has variable presentation, ranging from hyposthenuria to end-stage renal disease (ESRD). Management of ESRD in SCD patients is froth with multiple challenges which has potential to impact negatively the outcome of the patient. Kidney transplant is the preferred renal replacement therapy in these patients. The objective of this case study is to report kidney transplant in a Nigerian young man with sickle cell nephropathy and to highlight the outcome and the challenges to kidney transplant in this patient. The index case is a 26-years-old sickle cell disease patient with ESRD complicated with cardiovascular, pulmonary, immunological, and infective challenges. These conditions were controlled, and the patient had a successful live-related kidney transplant. Kidney transplant is a viable option for sickle cell disease patients with ESRD. 1. Introduction Sickle cell disease (SCD) is a haematological disorder associated with multisystemic complications and manifestations [1]. Sickle cell nephropathy (SCN) leads to both renal functional disturbances and anatomical alterations. The prevalence of renal disease (SCN) in SCA patients is about 25% [2]. The clinical spectrum of SCN include proteinuria, haematuria, nephrotic syndrome, acute renal failure, and chronic progressive renal failure leading to end-stage renal disease (ESRD). Mechanisms of SCN include fortuitous occurrence, iron overload and its subsequent deposition in the kidney parenchyma, immune complex formations, and focal segmental glomerulosclerosis (FSGS) associated with glomerular hyperfiltration and intrinsic glomerular capillary injury [3, 4]. Treatment of sickle cell nephropathy is fraught with many challenges as a result of antecedent complications prevalent in sickle cell disease patients. The outcome of treatment is usually variable. Renal replacement therapy is inevitable in SCN patients with uraemia, circulatory overload including pulmonary oedema and ESRD. Kidney transplant is usually renal replacement therapy of choice for eligible patients with ESRD barring other challenges and limitations. SCD and prevailing complications worsen these challenges, further limiting the prevalence of kidney transplant in these patients. However, in Nigeria and most developing countries kidney transplant is not readily available as a result of some factors which include poverty, ignorance, lack of transplant centres, and lack of donors [5]. There are only 4 kidney transplant centres in Nigeria performing less than 20

References

[1]  O. S. Platt, D. J. Brambilla, W. F. Rosse et al., “Mortality in sickle cell disease—life expectancy and risk factors for early death,” The New England Journal of Medicine, vol. 330, no. 23, pp. 1639–1644, 1994.
[2]  R. J. Falk, J. I. Scheinman, G. I. Phillips, E. Orringer, A. Johnson, and J. C. Jennette, “Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme,” The New England Journal of Medicine, vol. 326, no. 14, pp. 910–915, 1992.
[3]  P. Saborio and J. I. Scheinman, “Sickle cell nephropathy,” Journal of the American Society of Nephrology, vol. 10, no. 1, pp. 187–192, 1999.
[4]  L. W. Status van Eps, Sickle cell disease. Atlas of kidney disease, CD Rom, 1–22, 2004.
[5]  U. H. Okafor, I. Ekwem, and F. S. Wokoma, “Challenges of kidney care in a resource poor nation: a study of private kidney care centre in Nigeria,” Nigerian Medical Journal, vol. 53, no. 1, pp. 47–50, 2012.
[6]  S. N. Chatterjee, “National study on natural history of allografts in sickle cell disease or trait,” Nephron, vol. 25, no. 4, pp. 199–201, 1980.
[7]  NIH Publications, The Management of Sickle Cell Disease: Renal Abnormalities in Sickle Cell Disease, chapter 19, 4th edition, 2002.
[8]  A. O. Ojo, T. C. Govaerts, R. L. Schmouder et al., “Renal transplantation in end-stage sickle cell nephropathy,” Transplantation, vol. 67, no. 2, pp. 291–295, 1999.
[9]  S. N. Chatterjee, “National study in natural history of renal allografts in sickle cell disease or trait: a second report,” Transplantation Proceedings, vol. 19, no. 2, supplement 2, pp. 33–35, 1987.
[10]  J. Janik and R. A. Seeler, “Perioperative management of children with sickle hemoglobinopathy,” Journal of Pediatric Surgery, vol. 15, no. 2, pp. 117–120, 1980.
[11]  NIH Publications, The Management of Sickle Cell Disease: Anaesthesia and Surgery, chapter 24, 4th edition, 2002.
[12]  P.-T. T. Pham, P.-C. T. Pham, A. H. Wilkinson, and S. Q. Lew, “Renal abnormalities in sickle cell disease,” Kidney International, vol. 57, no. 1, pp. 1–8, 2000.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413